NCT00485472View on ClinicalTrials.gov

Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee

PHASE2TerminatedINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

January 31, 2008

Conditions

Osteoarthritis

Interventions

DRUG

lacosamide

50 or 100mg tablet, 400mg daily, for 12 weeks

OTHER

Placebo

50 or 100mg tablet, 400mg daily, for 12 weeks, matched to Lacosamide

Trial Locations (26)

Unknown

Kladno

Prague

Bad Hersfeld

Berlin

Hamburg

Leipzig

München

Debrecen

Esztegom

Győr

Gyula

Verseghy

Veszprém

Bialystok

Krakow

Torun

Warsaw

Brăila

Lasi

Târgovişte

Timișoara

Stockholm

Morriston

Newcastle

Oxford

Stanmore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY